New drugs, cancer and diabetes treatments top ACS Boston meeting in August

August 13, 2002

Developing new drugs, fighting cancer with nutrition, treating diabetes and measuring blood sugar levels non-invasively, are among the research scheduled to be presented at the American Chemical Society's 224th national meeting in Boston August 18-22.

In addition to research findings, several ACS technical divisions are featuring discussions on the role of chemists and biochemists in the nation's homeland security efforts. One such session will be held Wednesday, August 21 and is sponsored by Society President Dr. Eli Pearce and organized by the Division of Chemical Toxicology. Entitled, "The Chemistry and Biology of Terrorism and Homeland Security," it will focus on cutting-edge developments in anthrax biology and ultra-sensitive chemical and biological detectors. Speakers at this session will include Penrose Albright, Ph.D., assistant director for homeland and national security of the White House Office of Science and Technology Policy, and James Hughes, Ph.D., director of the National Centers for Disease Control.

ACS, the world's largest scientific society, expects approximately 11,000 scientists to attend its meeting. More than 7,000 papers have been submitted for presentation at the technical sessions which will be held at the Hynes Convention Center, 900 Boylston St., and surrounding hotels.

In conjunction with the ACS meeting, a special "master class" will be held for science reporters on chemical genomics. Experts in this field will examine this new frontier of the post-genome world. Chemical genomics - the integration of knowledge, the tools and the technologies from biology and chemistry - is viewed as an area that can help researchers identify targets of medical interest and accelerate the discovery of new drug therapies. The "master class" is tentatively scheduled to be held Monday, August 19.

In addition to the scientific research, the American Chemical Society is hosting events focusing on science education, career development and chemistry's contributions to society. There will also be an exhibition Monday through Wednesday by more than 300 companies providing goods and services of interest to the chemical community.

Other symposia and topics on the Boston program are:

American Chemical Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to